Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Sales        
Sales $ 100,075 $ 115,715 $ 281,187 $ 343,924
Cost of goods sold 64,527 76,291 178,864 216,566
Gross profit 35,548 39,424 102,323 127,358
Operating expenses        
Selling, general and administrative 31,790 32,340 94,809 101,959
Restructuring charges 1,099   1,835  
Transaction costs 842 858 975 2,880
Contingent consideration expense   104 (1,565) 493
Total operating expenses 33,731 33,302 96,054 105,332
Operating income 1,817 6,122 6,269 22,026
Other expense        
Interest expense, net (2,842) (2,216) (8,445) (5,060)
Other, net (443) (1,238) (134) (2,648)
Total other expense, net (3,285) (3,454) (8,579) (7,708)
(Loss) income before income tax (1,468) 2,668 (2,310) 14,318
Income tax benefit (204) (83) (553) 2,494
Net (loss) income (1,264) 2,751 (1,757) 11,824
Other comprehensive loss, net of tax:        
Foreign currency translation adjustment (3,539) (11,386) (5,949) (22,941)
Unrealized gain on hedging activities 401 268 347 976
Other comprehensive loss (3,138) (11,118) (5,602) (21,965)
Comprehensive loss $ (4,402) $ (8,367) $ (7,359) $ (10,141)
Net (loss) income per share:        
Basic $ (0.03) $ 0.07 $ (0.05) $ 0.32
Diluted $ (0.03) $ 0.07 $ (0.05) $ 0.30
Weighted average shares outstanding:        
Basic 37,470 37,369 37,267 37,256
Diluted 37,470 39,580 37,267 39,694
Domestic sales        
Sales        
Sales $ 44,152 $ 55,540 $ 135,724 $ 181,920
International sales        
Sales        
Sales $ 55,923 $ 60,175 $ 145,463 $ 162,004